Outset Medical, Inc. — Director's Dealing 2021

Jun 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Outset Medical, Inc. (OM)
CIK: 0001484612
Period of Report: 2021-06-01

Reporting Person: GROSSMAN D KEITH (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-01	Common Stock	M	1296	$1.11	Acquired	1296	Direct
2021-06-01	Common Stock	S	1296	$47.9181	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Non-Qualified Stock Option (right to buy)	$1.11	M	1296	Disposed	2024-06-16	Common Stock (1296)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11604	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.47 to $48.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: This option vested 25% on April 15, 2015 and then in 36 equal monthly installments thereafter.